D-dimer Levels as Novel Biomarker Predictor for All-cause Inhospital Mortality Risk in COVID-19 Patients

Authors

DOI:

https://doi.org/10.21776/ub.hsj.2021.002.04.4

Keywords:

D-dimer, death, mortality, all-cause inhospital mortality, COVID-19.

Abstract

BACKGROUND: COVID-19 has infected the world on a wide spectrum, from mild to severe and causing death. As of January 1st 2021, global case fatality rate (CFR) was 2.2 % due to COVID-19. CFR in Kediri district is 7.7 %, higher than Nasional CFR which is only 3 %. We analysed elevated D-dimer as one of predictor inhospital mortality in COVID-19

OBJECTIVES: To determine the association and evaluate the optimal cut off point D-dimer level as predictor for all-cause inhospital mortality of COVID-19 patients.

METHODS: This is a single center cross sectional. A total of 185 COVID-19 patients confirmed positive by RT-PCR were hospitalized at Kediri General Hospital since March to December 2020 met the inclusion criteria. D-dimer levels were categorized into 2 groups, above and below the cut of point. We analyzed 4 cut of points, D-dimer ≥ 0.5 µg/ml, D-dimer ≥ 2 µg/ml, D-dimer ≥ 3 µg/ml, and D-dimer ≥ 4 µg/ml. The primary endpoint was all-cause inhospital mortality. Data were collected retrospectively and processed using SPSS version 25.0.

RESULTS:

During hospitalization, 45 patients (24.3%) were died. Elevated D-dimer ≥ 4 µg/ml was statistically significant associated with all-cause inhospital mortality (adjusted OR95%CI = 3.46 [1.41 – 8.49], p = 0.007), with a sensitivity of 82.1% and a specificity of 42.2% (AUC, 0.628; 95% CI, 0.527 – 0.728, p = 0.012).

CONCLUSION: Elevated D-dimer level were associated statistically significant with all-cause inhospital mortality. In our study, optimal cut of point D-dimer value was 4 µg/ml.

References

WHO. Coronavirus Disease (COVID-19) [Internet]. 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey=%7Badgroupsurvey%7D&gclid=CjwKCAjw9MuCBhBUEiwAbDZ-7kLiP52ADvAbOjIf5NZkyRGkcN6D3LHi9n0pHjVPAVv1bNf-POlT0hoCs8gQAvD_BwE

RI KK. Situasi Terkini Perkembangan Coronavirus Disease (COVID-19) 17 Maret 2021. Infeksi Emerging (Media Informais Resmi Terkini Penyakit Infeksi Emerging). 2021.

Kediri PK. Data Statistik COVID-19 Kabupaten Kediri. 2021.

Timur PPJ. Peta Sebaran COVID-19 Jatim. 2021.

National Institutes of Health. Clinical Spectrum | COVID-19 Treatment Guidelines [Internet]. 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/

Leentjens J, van Haaps TF, Wessels PF, Schutgens REG, Middeldorp S. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol [Internet]. 2021;3026(21):1–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33930350%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8078884

Gomez-Mesa JE, Galindo-Coral S, Montes MC, Martin A es JM. Thrombosis and Coagulopathy in COVID-19. curr probl cardiol [Internet]. 2021;46(1):1–9. Available from: https://doi.org/10.1016/j.tmaid.2020.101607%0Ahttps://doi.org/10.1016/j.ijsu.2020.02.034%0Ahttps://onlinelibrary.wiley.com/doi/abs/10.1111/cjag.12228%0Ahttps://doi.org/10.1016/j.ssci.2020.104773%0Ahttps://doi.org/10.1016/j.jinf.2020.04.011%0Ahttps://doi.o

Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, et al. Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis (Thrombosis Journal, (2020), 18, 1, (34), 10.1186/s12959-020-00248-5). Thromb J. 2020;18(1):1–12.

Huang Y, Lyu X, Li D, Wang L, Wang Y, Zou W, et al. A cohort study of 676 patients indicates Ddimer is a critical risk factor for the mortality of COVID-19. PLoS One [Internet]. 2020;15(11 November):1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0242045

Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324–9.

Soni M, Gopalakrishnan R, Vaishya R, Prabu P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020;14(6):2245–9. Available from: https://doi.org/10.1016/j.dsx.2020.11.007

He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep [Internet]. 2021;11(1):1–7. Available from: https://doi.org/10.1038/s41598-021-81300-w

Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, et al. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021;49(5):e500–11.

Hoffbrand AV, Moss PAH. Hoffbrand’s Essential Haematology. Seventh. London, UK: John Wiley & Sons; 2016. 277 p.

Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020;189(6):1044–9.

Mezalek ZT, Khibri H, Ammouri W, Bouaouad M, Haidour S, Harmouche H, et al. COVID-19 Associated Coagulopathy and Thrombotic Complications. Clin Appl Thromb. 2020;26.

Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–65.

Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8(1):1–11.

Downloads

Published

2021-10-31